SK3 Group, Inc.
SKTO
Other OTC0.00
USD
- -
- -
ISIN
US78440L1070
CUSIP
78440L107
Return %
Stock
S&P500
1Y
-50.00
26.84
3Y
900.00
77.03
5Y
-90.00
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Artemus Mayor
- Full Time Employees
- 15
- Sector
- Consumer Cyclical
- Industry
- Specialty Retail
- Address
- 448 South Hill Street Los Angeles CA United States of America 90013
- IPO Date
- May 15, 2008
- Website
- sk3group.com
- Similar Companies
- Business
- SK3 Group, Inc. operates primarily in the healthcare services sector, focusing on management advisory, licensing, and marketing services for medical marijuana collectives in California. Its core offerings include licensing and marketing of cannabis-related products such as the YAK line of medical marijuana edibles; Canna-Loz, a delivery system for large doses of phyto-cannabinoids; Yeti, a pre-roll product for pain relief; and Dharmanol, a proprietary technology for extracting, stabilizing, and preserving medicinal cannabinoids in their non-psychoactive form. The company also provides administrative, financial, legal, and accounting services tailored for medical marijuana collectives, primarily within California through its subsidiary Medical Greens. Founded in 2000 and headquartered in Los Angeles, California, SK3 Group is a subsidiary of Healthcare of Today, Inc. Recent operational developments include a historical strategic focus on acquiring companies with cash flowing operations, such as the definitive agreement to acquire Paragon Consulting Group. Though there are no publicly reported large-scale acquisitions or major changes in the last 1-2 years, the company continues to extend its range of cannabis-related licensing and management services for medical marijuana collectives. SK3 Group remains focused on expanding and enhancing its product portfolio and service offerings in the California medical marijuana market. The company targets medical marijuana collectives as its primary customer base and operates mainly within the geographic confines of California. Its services and licensed products support these collectives in compliance, marketing, and operational efficiency. SK3 Group also holds a strategic position in specialty healthcare retail linked to cannabis products, positioning it within the growing cannabis and healthcare regulatory landscape. Overall, SK3 Group, Inc. maintains a comprehensive portfolio of medical marijuana-related licensing, marketing, and operational support services, underpinned by proprietary cannabinoid technologies and a strategic acquisition approach aimed at broadening its business footprint within California’s evolving cannabis industry. This description reflects SK3 Group's current business model, product lines, geographic emphasis, and recent strategic moves as of late 2025.